dpp4i and glp 1 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner DPP-4 inhibitors and GLP-1RAs: cardiovascular

Clinical trials have demonstrated that Mounjaro effectively lowers HbA1c (a marker of long-term blood glucose control) and body weight in people with type 2 diabetes

59% Increase in total sleep time vs placebo (controlled study) 37 mo Normal sleep maintained after the last dose (chronic insomniacs) 1977 Year DSIP was first isolated 0 Documented dependence or withdrawal in clinical studies Studies show increased delta wave sleep Research on cortisol normalization Trials in chronic pain patients Demonstrated stress-reducing effects What to expect Your DSIP timeline

Lifestyle and IVF outcomes

Retatrutide doesnt directly interact with thyroid medication, but weight loss may require thyroid dose adjustment

Phytomedicine 2000;7:273-82